The True Cost: Why life-saving drugs are so inaccessible and how one student group is working to change that
Taxpayers shelled out at least $3.8 million to help develop a cancer drug that offers new promise to patients with chronic lymphocytic leukemia.
It now costs over $194,000 per year for those who need it.
For people suffering from various rare forms of blood cancer, acalabrutinib offers the promise of improved life quality by reducing serious side effects — namely suppressed immune systems that left patients dangerously vulnerable to infect...
It now costs over $194,000 per year for those who need it.
For people suffering from various rare forms of blood cancer, acalabrutinib offers the promise of improved life quality by reducing serious side effects — namely suppressed immune systems that left patients dangerously vulnerable to infect...